Crossmark

Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia

Published Online: 2014-11-14

Authors

Castro, J E

Choi, M Y

Carvajal, T

Almahasnah, E

Chang, J

James, D F

Kipps, T J
License Information

Text and Data Mining valid from 2014-11-14

Version of Record valid from 2014-11-14
More Information

Article History

Received: 30 June 2014

Accepted: 6 August 2014

First Online: 14 November 2014

Competing interests

: The authors declare no conflict of interest.

Document is current